Oncorus, Inc(NASDAQ:ONCR) 
Oncorus, Inc., a clinical stage biopharmaceutical company, focuses on developing viral immunotherapies for cancer patients. The company's lead product candidate is ONCR-177, an intratumorally administered viral immunotherapy based on its oncolytic herpes simplex virus type 1 platform, which is in Ph...
Website: http://www.oncorus.com
Founded: 2015
Full Time Employees: 51
CEO: Theodore T. Ashburn
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
The information provided in this report is taken from www.sec.gov. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Day
Week
Month
Date 2023-07-05
P
O 0.04
H 0.05
L 0.04
C 0.04
V 490,436
10EMA 0.04
20EMA 0.04
60EMA 0.04
120EMA 0.04
250EMA 0.04